You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Related Products Videos on Diabetes Health TV
Simple Choice Twist
Author Dispels Diabetes Myths
Prodigy Talking Meter
Popular Eli Lilly Articles
Highly Recommended Eli Lilly Articles
Students with type 1 diabetes will have more opportunity for higher education thanks to a donation from Lilly Diabetes.
0 comments - Feb 9, 2013 -
Lilly Diabetes recently launched the free Lilly Glucagon Mobile App to educate those who support people living with type 1 diabetes. The interactive app, available on the iTunes store for iPhone and iPad devices, provides caregivers, diabetes educators, and school nurses with visual and audio emergency instructions, as well as tools to track locations of glucagon kits and alerts for expiration dates.
0 comments - Sep 23, 2012 -
Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company have introduced My Well Planner, a new online program offering customized educational content to help adults with type 2 diabetes make simple lifestyle changes to improve their health. Sample topics include general information about type 2 diabetes, better eating habits, building physical activity into daily life, taking medication, and communication strategies.
0 comments - Sep 22, 2012 -
Several hopeful trends emerged from this year's ADA Scientific Sessions in Philadelphia, held June 8 through 12.
0 comments - Jun 23, 2012 -
0 comments - Mar 10, 2012 -
Diabetes Health publisher Nadia Al-Samarrie recently spoke with television and movie actor Anthony Anderson, who has taken a lead role with Eli Lilly & Company's F.A.C.E. campaign, a diabetes outreach to African Americans. A veteran of more than 20 films, Anthony, age 41, currently plays Detective Kevin Bernard on NBC's Emmy Award-winning drama, "Law & Order."
0 comments - Nov 27, 2011 -
Boehringer Ingelheim and Eli Lilly have begun sales of Tradjenta, a drug for type 2 diabetes, in U.S. pharmacies. The drug (generic name linagliptin) comes in tablet form and is intended to compete with Amylin Pharmaceuticals' Byetta, which is injected, and Merck's Januvia, which also competes with Byetta. Both are well-established in the U.S. market.
0 comments - Jul 27, 2011 -
French drug maker Sanofi-aventis says that results from a Phase III trial of its experimental type 2 diabetes drug lixisenatide show that the drug successfully lowered patients' blood glucose levels and body weight, but did not increase the risk of hypoglycemia.
0 comments - May 23, 2011 -
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.